TrialsgrambetaRCTs are beautiful

ED sepsis resuscitation

Early goal-directed therapy and the trials that ended it, MAP targets, capillary refill and conservative-fluid resuscitation.

  • 2023CLOVERS⁠Fluid strategyIn 1,563 patients with sepsis-induced hypotension after 1–3 L fluid, a restrictive-fluid strategy with early vasopressors did not change 90-day mortality compared with a liberal-fluid strategy.14.0% vs 14.9%Read →
  • 2018PHANTASi⁠In 2672 adults with suspected sepsis, prehospital ceftriaxone in the ambulance did not reduce 28-day all-cause mortality compared with usual care.RR 0.9595% CI 0.74-1.24Read →
  • 2015ProMISe Core⁠Resuscitation bundlesIn 1,260 UK patients with early septic shock, EGDT did not reduce 90-day all-cause mortality compared with usual care, and increased ICU length of stay.RR 1.01Read →
  • 2014ProCESS Core⁠Resuscitation bundlesIn 1,341 patients with early septic shock, protocol-based EGDT or protocol-based standard care did not reduce 60-day in-hospital mortality compared with usual care.Read →
  • 2014ARISE Core⁠Resuscitation bundlesIn 1,600 patients with early septic shock, EGDT did not change 90-day all-cause mortality versus usual care.18.6% vs 18.8%Read →
  • 2014SEPSISPAM⁠MAP targetsIn 776 patients with septic shock, targeting MAP 80–85 mm Hg did not change 28-day mortality versus MAP 65–70 mm Hg, but reduced renal-replacement therapy in chronic hypertension.HR 1.0795% CI 0.84-1.38Read →
  • 2011FEAST⁠In 3170 African children with severe febrile illness and impaired perfusion, fluid boluses increased 48-hour mortality compared with no bolus.RR 1.4595% CI 1.13-1.86Read →